PANACEA BIOTEC
Quarterly Results Analysis [Dec2024]
PANACEA BIOTEC Quarterly Results
Consolidated | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 Audited |
Jun2023 UnAudited |
Mar2023 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹163 Cr | ₹147 Cr | ₹116 Cr | ₹136 Cr | ₹151 Cr | ₹143 Cr | ₹129 Cr | ₹129 Cr |
Expenses | ₹156 Cr | ₹140 Cr | ₹130 Cr | ₹143 Cr | ₹151 Cr | ₹147 Cr | ₹140 Cr | ₹135 Cr |
Operating Income | ₹8 Cr | ₹7 Cr | ₹-14 Cr | ₹-6 Cr | ₹0 Cr | ₹-4 Cr | ₹-10 Cr | ₹-6 Cr |
Other Income | ₹4 Cr | ₹5 Cr | ₹4 Cr | ₹11 Cr | ₹6 Cr | ₹3 Cr | ₹6 Cr | ₹15 Cr |
Interest | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Depreciation | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹10 Cr |
Profit Before Tax | ₹4 Cr | ₹5 Cr | ₹-17 Cr | ₹-2 Cr | ₹-2 Cr | ₹-8 Cr | ₹13 Cr | ₹18 Cr |
Profit After Tax | ₹4 Cr | ₹5 Cr | ₹-16 Cr | ₹-2 Cr | ₹-2 Cr | ₹-8 Cr | ₹11 Cr | ₹-13 Cr |
EPS | ₹0.74 | ₹0.78 | ₹-2.58 | ₹-0.23 | ₹-0.37 | ₹-1.37 | ₹1.78 | ₹-2.02 |
Industry Peers & Returns | 1W | 1M | 1Y |
PANACEA BIOTEC | -5.7% | 5.6% | 262.7% |
SUN PHARMACEUTICAL INDUSTRIES | -4.9% | 2.1% | 15.5% |
DIVIS LABORATORIES | -2.2% | 9.3% | 50.5% |
CIPLA | -4.2% | 4.5% | 4.5% |
TORRENT PHARMACEUTICALS | -4.4% | -4.5% | 17.2% |
DR REDDYS LABORATORIES | -1.4% | 4.2% | -8.8% |
MANKIND PHARMA | -0.1% | -1.5% | 6.6% |
ZYDUS LIFESCIENCES | -1.6% | 1.3% | -14.6% |
LUPIN | -2.4% | 3.4% | 19.9% |
PANACEA BIOTEC Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 10.95 % |
Y-o-Y | 8.63 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹163 Cr | 10.95 | |
Sep2024 | ₹147 Cr | 27.33 | |
Jun2024 | ₹116 Cr | -15.20 | |
Mar2024 | ₹136 Cr | -9.33 | |
Dec2023 | ₹151 Cr | 5.23 | |
Sep2023 | ₹143 Cr | 10.71 | |
Jun2023 | ₹129 Cr | 0.20 | |
Mar2023 | ₹129 Cr | - |
PANACEA BIOTEC Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 13.71 % |
Y-o-Y | Positive |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹8 Cr | 13.71 | |
Sep2024 | ₹7 Cr | Positive | |
Jun2024 | ₹-14 Cr | Negative | |
Mar2024 | ₹-6 Cr | Negative | |
Dec2023 | ₹0 Cr | Negative | |
Sep2023 | ₹-4 Cr | Negative | |
Jun2023 | ₹-10 Cr | Negative | |
Mar2023 | ₹-6 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 2.53 % |
Y-o-Y | Positive |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 4.87% | 2.53 | |
Sep2024 | 4.75% | Positive | |
Jun2024 | -12.09% | Negative | |
Mar2024 | -4.43% | Negative | |
Dec2023 | -0.1% | Negative | |
Sep2023 | -2.49% | Negative | |
Jun2023 | -7.98% | Negative | |
Mar2023 | -4.4% | - |
PANACEA BIOTEC Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -5.73 % |
Y-o-Y | Positive |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹4 Cr | -5.73 | |
Sep2024 | ₹5 Cr | Positive | |
Jun2024 | ₹-16 Cr | Negative | |
Mar2024 | ₹-2 Cr | Negative | |
Dec2023 | ₹-2 Cr | Negative | |
Sep2023 | ₹-8 Cr | Negative | |
Jun2023 | ₹11 Cr | Positive | |
Mar2023 | ₹-13 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -15.00 % |
Y-o-Y | Positive |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 2.72 % | -15.00 | |
Sep2024 | 3.2 % | Positive | |
Jun2024 | -13.72 % | Negative | |
Mar2024 | -1.46 % | Negative | |
Dec2023 | -1.46 % | Negative | |
Sep2023 | -5.8 % | Negative | |
Jun2023 | 8.5 % | Positive | |
Mar2023 | -9.83 % | - |
PANACEA BIOTEC Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -5.13 % |
Y-o-Y | Positive |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹0.74 | -5.13 | |
Sep2024 | ₹0.78 | Positive | |
Jun2024 | ₹-2.58 | Negative | |
Mar2024 | ₹-0.23 | Negative | |
Dec2023 | ₹-0.37 | Negative | |
Sep2023 | ₹-1.37 | Negative | |
Jun2023 | ₹1.78 | Positive | |
Mar2023 | ₹-2.02 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD